Safety and efficacy of lixisenatide vs sulfonylurea added to basal insulin in patients with type 2 diabetes who fast during Ramadan (LixiRam): a randomised controlled trial

被引：0
|
作者：
Hassanein, M. M. [1 ]
Hafidh, K. [2 ]
Shehadeh, N. [3 ]
Azar, S. [4 ]
Hanif, W. [5 ]
Li, H. [6 ]
Djaballah, K. [7 ]
Sahay, R. [8 ]
机构：
[1] Dubai Hosp, Dubai, U Arab Emirates
[2] Rashid Hosp, Dubai, U Arab Emirates
[3] Rambam Med Ctr, Haifa, Israel
[4] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[5] Univ Hosp Birmingham, Birmingham, W Midlands, England
[6] Sanofi Aventis China, Beijing, Peoples R China
[7] Sanoti, Paris, France
[8] Osmania Med Coll & Hosp, Hyderabad, Telangana, India
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
757
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [31] The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan
    Rohban, T
    Khadija, B
    Maamoun, M
    Khaled, O
    Hisham, E
    Moghazy, M
    Raefat, R
    Salah, S
    Assem, Z
    Mohammed, A
    Nidal, E
    Ramzi, E
    Jihad, H
    Oussama, M
    Hassan, S
    Asman, M
    Ida, AK
    Khalid, A
    Mustaffa, E
    Bebakar, W
    Mohamad, KW
    Nazih, A
    Akram, E
    Camille, E
    Sami, F
    Fadl, F
    Ahmad, G
    Said, H
    Yahya, J
    Karim, KA
    Marwan, K
    Mamdouh, M
    Haitham, R
    Dolly, MV
    Ali, M
    Hicham, N
    Issam, Y
    DIABETES CARE, 2005, 28 (02) : 421 - 422
  • [32] Efficacy and safety of liraglutide added to capped insulin treatment in type 1 diabetes, the ADJUNCT TWO™ randomised trial
    Hirsch, I. B.
    Ahren, B.
    Pieber, T.
    Mathieu, C.
    Gomez-Peralta, F.
    Hansen, T.
    Philotheou, A.
    Christiansen, E.
    Jensen, T. J.
    Birch, S.
    Buse, J.
    DIABETOLOGIA, 2016, 59 : S357 - S357
  • [33] Efficacy and Safety of Exenatide QW vs. Placebo Added to Insulin Glargine in Uncontrolled Basal-Insulin Treated Type 2 Diabetes: DURATION-7 Trial
    Frias, Juan P.
    Rosenstock, Julio
    Somogyi, Aniko
    Jabbour, Serge A.
    Wang, Hui
    Hardy, Elise
    Guja, Cristian
    DIABETES, 2017, 66 : A34 - A35
  • [34] Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial
    Billings, L. K.
    Doshi, A.
    Gouet, D.
    Oviedo, A.
    Rodbard, H. W.
    Tentolouris, N.
    Gron, R.
    Halladin, N.
    Jodar, E.
    DIABETOLOGIA, 2017, 60 : S366 - S366
  • [35] Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
    Halberg, Inge B.
    Lyby, Karsten
    Wassermann, Karsten
    Heise, Tim
    Zijlstra, Eric
    Plum-Moerschel, Leona
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (03): : 179 - 188
  • [36] Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
    Vilsboll, T.
    Rosenstock, J.
    Yki-Jarvinen, H.
    Cefalu, W. T.
    Chen, Y.
    Luo, E.
    Musser, B.
    Andryuk, P. J.
    Ling, Y.
    Kaufman, K. D.
    Amatruda, J. M.
    Engel, S. S.
    Katz, L.
    DIABETES OBESITY & METABOLISM, 2010, 12 (02): : 167 - 177
  • [37] Efficacy and Safety of Liraglutide Added to Insulin Therapy in Elderly Patients with Type 2 Diabetes
    Tonoike, Mie
    Chujo, Daisuke
    Noda, Mitsuhiko
    DIABETES, 2017, 66 : A301 - A301
  • [38] Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin
    Bajaj, H.
    Isendahl, J.
    Gowda, A.
    Stachlewska, K.
    Rosenstock, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S317 - S317
  • [39] Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan
    Kobeissy, Abdallah
    Zantout, Mira S.
    Azar, Sami T.
    CLINICAL THERAPEUTICS, 2008, 30 (08) : 1408 - 1415
  • [40] Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes
    Tonoike, Mie
    Chujo, Daisuke
    Noda, Mitsuhiko
    ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (01)
12345